Showing results (101-110 of 245) with videos related to

Sort By:
Pageof 25
The Journal of Organic Chemistry|June 15, 2021
Deconjugative α-Alkylation of Cyclohexenecarboxaldehydes: An Access to Diverse TerpenoidsRachid Chahboun, José Manuel Botubol-Ares, María Jesús Durán-Peña, et al.
Molecular and Cellular Endocrinology|September 20, 2021
Stem/progenitor cells in normal physiology and disease of the pancreasMario Enrique Alvarez Fallas, Sergio Pedraza-Arevalo, Ana-Maria Cujba, et al.
Chemical Biology & Drug Design|June 26, 2026
Design, Optimization and Mechanistic Insights Into Terpenoid-Derived Inhibitors of Protein Kinase C IotaRachid Chahboun, Fernando Rodríguez-Serrano, Ángel Bueno, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2007
Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cellsMaría J Muñoz-Alonso, Laura González-Santiago, Natasha Zarich, et al.
Virology|April 23, 2010
The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinatedEnrique Alvarez, Marta L DeDiego, Jose L Nieto-Torres, et al.
Revista De Psiquiatria Y Salud Mental|March 1, 2013
[Pyschotherapygenetics. Do genes influence psychotherapy adherence?]Víctor Pérez, Juan Carlos Pascual, Joaquim Soler, et al.
Frontiers in Public Health|March 26, 2024
A mixture of mobility and meteorological data provides a high correlation with COVID-19 growth in an infection-naive population: a study for Spanish provincesDavid Conesa, Víctor López de Rioja, Tania Gullón, et al.
Multiple Sclerosis and Related Disorders|September 23, 2019
Rituximab-induced serum sickness in multiple sclerosis patientsAndrew B Wolf, Lana Zhovtis Ryerson, Krupa Pandey, et al.
Journal of Natural Products|January 26, 2017
Antiproliferative Activity of Natural Taiwaniaquinoids and Related CompoundsJuan J Guardia, Rubén Tapia, Soumicha Mahdjour, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related ReactionsEnrique Alvarez, Kavita V Nair, Stefan Sillau, et al.
Pageof 25